Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

capsensixx

DB:CPX
Snowflake Description

Adequate balance sheet with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CPX
DB
€22M
Market Cap
  1. Home
  2. DE
  3. Diversified Financials
Company description

Capsensixx AG provides engages in the financial administration as a service business. The last earnings update was 133 days ago. More info.


Add to Portfolio Compare Print
CPX Share Price and Events
7 Day Returns
-5.3%
DB:CPX
3%
DE Capital Markets
2.2%
DE Market
1 Year Returns
-38.7%
DB:CPX
-6.9%
DE Capital Markets
-17.2%
DE Market
CPX Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
capsensixx (CPX) -5.3% -10.1% -14.4% -38.7% - -
DE Capital Markets 3% -17.7% -13.1% -6.9% -24.7% -54.9%
DE Market 2.2% -15.7% -24% -17.2% -23.3% -27.8%
1 Year Return vs Industry and Market
  • CPX underperformed the Capital Markets industry which returned -6.9% over the past year.
  • CPX underperformed the Market in Germany which returned -17.2% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

CPX Value

 Is capsensixx undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of capsensixx to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for capsensixx.

DB:CPX Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Excess Returns Model
Stable EPS Median Return on Equity from the past 5 years.
= Stable Book Value * Return on Equity
= €3.20 * 26%
€0.83
Book Value of Equity per Share Median Book Value from the past 5 years. €3.20
Discount Rate (Cost of Equity) See below 4.1%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:CPX
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 5.4%
Capital Markets Unlevered Beta Simply Wall St/ S&P Global 0.75
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.753 (1 + (1- 30%) (0%))
0.834
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.83
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (0.834 * 5.44%)
4.15%

Discounted Cash Flow Calculation for DB:CPX using Excess Returns Model Model

The calculations below outline how an intrinsic value for capsensixx is arrived at using the Excess Return Model. This approach is used for finance firms where free cash flow is difficult to estimate.

In the Excess Return Model the value of a firm can be written as the sum of capital invested currently in the firm and the present value of excess returns that the firm expects to make in the future.

The model is sensitive to the Return on Equity of the company versus the Cost of Equity, how these are calculated is detailed below the main calculation.

Note the calculations below are per share.

See our documentation to learn about this calculation.

DB:CPX Value of Excess Returns
Calculation Result
Excess Returns = (Stable Return on equity – Cost of equity) (Book Value of Equity per share)
= (26% – 4.15%) * €3.20)
€0.70
Terminal Value of Excess Returns = Excess Returns / (Cost of Equity - Expected Growth Rate)
= €0.70 / (4.15% - -0.39%)
€15.42
Value of Equity = Book Value per share + Terminal Value of Excess Returns
= €3.20 + €15.42
€18.62
DB:CPX Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:CPX represents 0.98425x of XTRA:CPX
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.98425x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (EUR) x Listing Adjustment Factor
= € 18.62 x 0.98425
€18.32
Value per share (EUR) From above. €18.32
Current discount Discount to share price of €6.25
= -1 x (€6.25 - €18.32) / €18.32
65.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price capsensixx is available for.
Intrinsic value
>50%
Share price is €6.25 vs Future cash flow value of €18.32
Current Discount Checks
For capsensixx to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • capsensixx's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • capsensixx's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for capsensixx's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are capsensixx's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:CPX PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in EUR €-0.06
XTRA:CPX Share Price ** XTRA (2020-04-01) in EUR €6.35
Germany Capital Markets Industry PE Ratio Median Figure of 16 Publicly-Listed Capital Markets Companies 22.55x
Germany Market PE Ratio Median Figure of 398 Publicly-Listed Companies 16.76x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of capsensixx.

DB:CPX PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= XTRA:CPX Share Price ÷ EPS (both in EUR)

= 6.35 ÷ -0.06

-115.19x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • capsensixx is loss making, we can't compare its value to the DE Capital Markets industry average.
  • capsensixx is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does capsensixx's expected growth come at a high price?
Raw Data
DB:CPX PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -115.19x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
65.6%per year
Germany Capital Markets Industry PEG Ratio Median Figure of 6 Publicly-Listed Capital Markets Companies 1.59x
Germany Market PEG Ratio Median Figure of 254 Publicly-Listed Companies 1.18x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for capsensixx, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on capsensixx's assets?
Raw Data
DB:CPX PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in EUR €3.20
XTRA:CPX Share Price * XTRA (2020-04-01) in EUR €6.35
Germany Capital Markets Industry PB Ratio Median Figure of 31 Publicly-Listed Capital Markets Companies 1.5x
Germany Market PB Ratio Median Figure of 570 Publicly-Listed Companies 1.44x
DB:CPX PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= XTRA:CPX Share Price ÷ Book Value per Share (both in EUR)

= 6.35 ÷ 3.20

1.99x

* Primary Listing of capsensixx.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • capsensixx is overvalued based on assets compared to the DE Capital Markets industry average.
X
Value checks
We assess capsensixx's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Capital Markets industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Capital Markets industry average (and greater than 0)? (1 check)
  5. capsensixx has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

CPX Future Performance

 How is capsensixx expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
65.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is capsensixx expected to grow at an attractive rate?
  • capsensixx's earnings growth is expected to exceed the low risk savings rate of -0.4%.
Growth vs Market Checks
  • capsensixx's earnings growth is expected to exceed the Germany market average.
  • capsensixx's revenues are expected to decrease over the next 1-3 years, this is below the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:CPX Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:CPX Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 65.6%
DB:CPX Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts -9%
Germany Capital Markets Industry Earnings Growth Rate Market Cap Weighted Average 39.4%
Germany Capital Markets Industry Revenue Growth Rate Market Cap Weighted Average 0.8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.5%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:CPX Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:CPX Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 86 6 3 1
2021-12-31 81 6 3 1
2020-12-31 74 5 2 1
2020-04-01
2019-12-31 99 6 0 1
DB:CPX Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-09-30 117 -1
2019-06-30 114 -1 0
2019-03-31 116 1
2018-12-31 116 6 1
2018-09-30 77 3
2018-06-30 134 8 3
2018-03-31 127 6 3
2017-12-31 117 5 3
2016-12-31 66 3 2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • capsensixx's earnings are expected to grow significantly at over 20% yearly.
  • capsensixx's revenue is expected to decrease over the next 1-3 years, this is not considered high growth.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:CPX Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from capsensixx Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:CPX Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 0.79 0.79 0.79 1.00
2021-12-31 0.72 0.72 0.72 1.00
2020-12-31 0.63 0.63 0.63 1.00
2020-04-01
2019-12-31 -0.09 -0.09 -0.09 1.00
DB:CPX Past Financials Data
Date (Data in EUR Millions) EPS *
2019-09-30
2019-06-30 -0.06
2019-03-31
2018-12-31 0.53
2018-09-30
2018-06-30 0.84
2018-03-31 0.86
2017-12-31 1.06
2016-12-31

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • capsensixx is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess capsensixx's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
capsensixx has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

CPX Past Performance

  How has capsensixx performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare capsensixx's growth in the last year to its industry (Capital Markets).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • capsensixx does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare capsensixx's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare capsensixx's 1-year growth to the DE Capital Markets industry average as it is not currently profitable.
Earnings and Revenue History
capsensixx's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from capsensixx Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:CPX Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 117.37 -0.66 1.79
2019-06-30 114.17 -0.19 1.79
2019-03-31 116.06 0.57 1.79
2018-12-31 116.42 1.27 1.79
2018-09-30 77.07 2.76 1.51
2018-06-30 134.05 2.88 1.51
2018-03-31 127.09 2.67 1.12
2017-12-31 116.73 2.53 1.51
2016-12-31 65.96 2.06 1.22
2015-12-31 70.10 2.44 0.92

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • capsensixx has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • It is difficult to establish if capsensixx has efficiently used its assets last year compared to the DE Capital Markets industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if capsensixx improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess capsensixx's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Capital Markets industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
capsensixx has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

CPX Health

 How is capsensixx's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up capsensixx's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • capsensixx is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • capsensixx's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of capsensixx's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are -493.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from capsensixx Company Filings, last reported 6 months ago.

DB:CPX Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 16.54 0.00 12.74
2019-06-30 16.54 0.00 12.74
2019-03-31 17.66 0.05 13.37
2018-12-31 17.66 0.00 13.37
2018-09-30
2018-06-30 15.78 0.00 13.88
2018-03-31 13.28 0.00 10.19
2017-12-31 11.58 0.00 8.13
2016-12-31 9.91 0.00 5.95
2015-12-31 10.23 0.00 8.43
  • Unable to establish if capsensixx's level of debt is high without past debt data.
  • Unable to establish if capsensixx's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (1262.2%, greater than 20% of total debt).
  • capsensixx has no debt, therefore coverage of interest payments is not a concern.
X
Financial health checks
We assess capsensixx's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. capsensixx has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

CPX Dividends

 What is capsensixx's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from capsensixx dividends. Estimated to be 4.36% next year.
If you bought €2,000 of capsensixx shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate capsensixx's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate capsensixx's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:CPX Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Germany Capital Markets Industry Average Dividend Yield Market Cap Weighted Average of 14 Stocks 3.2%
Germany Market Average Dividend Yield Market Cap Weighted Average of 322 Stocks 3.8%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.6%
Germany Top 25% Dividend Yield 75th Percentile 4.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:CPX Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2022-12-31 0.37 1.00
2021-12-31 0.23 1.00
2020-12-31 0.23 1.00
2020-04-01
2019-12-31 0.11 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as capsensixx has not reported any payouts.
  • Unable to verify if capsensixx's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of capsensixx's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as capsensixx has not reported any payouts.
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (2.3x coverage).
X
Income/ dividend checks
We assess capsensixx's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can capsensixx afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. capsensixx has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

CPX Management

 What is the CEO of capsensixx's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • capsensixx has no CEO, or we have no data on them.
Management Team

Fabian Föhre

TITLE
CFO, MD & Member of the Management Board
AGE
45

Gregor Langer

TITLE
Member of Management Board
AGE
56
TENURE
0.3 yrs
Board of Directors

Martin Stürner

TITLE
Chairman of the Supervisory Board
AGE
58

Rudolf Locker

TITLE
Member of the Supervisory Board
AGE
71
TENURE
2.4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess capsensixx's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. capsensixx has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

CPX News

Simply Wall St News

What Kind Of Shareholders Own capsensixx AG (FRA:CPX)?

With a market capitalization of €33m, capsensixx is a small cap stock, so it might not be well known by many institutional investors. … Our analysis of the ownership of the company, below, shows that institutions own shares in the company. … View our latest analysis for capsensixx DB:CPX Ownership Summary, July 25th 2019 What Does The Institutional Ownership Tell Us About capsensixx?

Simply Wall St -

Volatility 101: Should capsensixx (FRA:CPX) Shares Have Dropped 40%?

Investors in capsensixx AG (FRA:CPX) have tasted that bitter downside in the last year, as the share price dropped 40%. … This fall in the EPS is significantly worse than the 40% the share price fall. … A Different Perspective capsensixx shareholders are down 40% for the year, even worse than the market loss of 0.02%.

Simply Wall St -

Should You Be Holding capsensixx AG (FRA:CPX)?

Investors have the opportunity to buy into the stock to reap capital gains, if CPX's projected earnings trajectory does follow analyst consensus growth, which determines my intrinsic value of the company. … DB:CPX Past and Future Earnings, June 12th 2019 CPX's ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. … Dividend Income vs Capital Gains: Does CPX return gains to shareholders through reinvesting in itself and growing earnings, or redistribute a decent portion of earnings as dividends?

Simply Wall St -

Want To Invest In capsensixx AG (FRA:CPX) Today? Read This First

capsensixx is poised for extremely high earnings growth in the near future. … CPX is available at a PE (price-to-earnings) ratio of 19.93x today, which tells us the stock is overvalued based on current earnings compared to the Capital Markets industry average of 19.77x , and undervalued relative to the current DE market average of 20.17x. … However, seeing as capsensixx is perceived as a high-growth stock, we must also account for its earnings growth, which is captured in the PEG ratio.

Simply Wall St -

What Should We Expect From capsensixx AG's (FRA:CPX) Earnings Over The Next Few Years?

Want to participate in a short research study? … Help shape the future of investing tools and you could win a $250 gift card! … The latest earnings release capsensixx AG's (FRA:CPX) announced in December 2018

Simply Wall St -

Could The capsensixx AG (FRA:CPX) Ownership Structure Tell Us Something Useful?

Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … We also tend to see lower insider ownership in companies that were previously publicly owned. … institutional investors have bought into the company.

Simply Wall St -

Who Are The Major Shareholders In capsensixx AG (FRA:CPX)?

In this article, I'm going to take a look at capsensixx AG’s (FRA:CPX) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … Ownership structure of a company has been found to affect share performance over time. … DB:CPX Ownership Summary August 30th 18

Simply Wall St -

Does Capsensixx AG's (FRA:CPX) PE Ratio Signal A Selling Opportunity?

This analysis is intended to introduce important early concepts to people who are starting to invest. … and want to begin learning the link between Capsensixx AG (FRA:CPX)’s fundamentals and stock market performance. … While CPX might seem like a stock to avoid or sell if you own it, it is important to understand the assumptions behind the P/E ratio before you make any investment decisions

Simply Wall St -

CPX Company Info

Description

Capsensixx AG provides engages in the financial administration as a service business. It offers fund management, administration, and accounting services; corporate and capital markets services that include advisory services to banks, insurance companies, and asset managers; and digitization and IT-services. The company is based in Frankfurt, Germany.

Details
Name: capsensixx AG
CPX
Exchange: DB
Founded:
€21,780,500
3,430,000
Website: http://www.capsensixx.de
Address: capsensixx AG
Bettinastrasse 57-59,
Frankfurt,
Hessen, 60325,
Germany
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
XTRA CPX Ordinary Bearer Shares XETRA Trading Platform DE EUR 12. Jun 2018
DB CPX Ordinary Bearer Shares Deutsche Boerse AG DE EUR 12. Jun 2018
Number of employees
Current staff
Staff numbers
95
capsensixx employees.
Industry
Asset Management and Custody Banks
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/01 23:30
End of day share price update: 2020/04/01 00:00
Last estimates confirmation: 2020/03/23
Last earnings filing: 2019/11/20
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.